ArticleEuropean journal of medical research2025
Preliminary identification of the MiR-548ah-5p/THBD axis for heart failure via DirectTarget causal framework and bioinformatics analysis.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundIdentifying putative direct regulatory interactions between microRNAs (miRNAs) and messenger RNAs (mRNAs) is crucial for understanding the molecular mechanisms of heart failure (HF). This exploratory study aimed to investigate these putative direct interactions within the miRNA-mRNA axis in HF.
methodsWe used the GSE135055 dataset to screen for differentially expressed miRNAs (DE-MiRNAs) and mRNAs (DE-mRNAs). To infer putative direct interactions between them, we applied the DirectTarget framework, utilizing the Interventional Calculus when the DAG is Absent (IDA) method for causal inference, combined with target information predicted from sequence data. We then constructed putative direct regulatory networks for the screened miRNA-mRNAs. Subsequently, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed on the genes in the putative regulatory network. Finally, the miRNA-mRNAs exhibiting the strongest negative regulatory relationships were experimentally validated in vitro using dual luciferase reporter assays, reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and western blotting. In addition, we further investigated the hub miRNA-mRNA expression and exploratory discriminatory ability.
resultsDifferential expression analysis between HF and control groups identified 31 miRNAs and 163 mRNAs. The resulting regulatory network comprised 348 putative direct miRNA-mRNA axes, involving 27 miRNAs and 116 mRNAs. Notably, the miR-548ah-5p/THBD pair exhibited the strongest negative regulatory relationship, while miR-4422 and TIFA were involved in the most regulatory interactions. GO enrichment analysis revealed that the extracellular matrix (ECM) was the most significantly enriched term. KEGG pathway analysis identified key pathways such as AGE-RAGE, PI3K-Akt, and ECM-receptor interactions. The gene THBD, with its high connectivity in the network was considered a potential key candidate. Our in vitro experiments further confirmed that miR-548ah-5p negatively regulates THBD expression. Receiver operating characteristic (ROC) analysis showed that miR-548ah-5p and THBD exhibit favorable exploratory classification ability for HF.
conclusionsThis study demonstrates the effectiveness of the DirectTarget framework in identifying putative miRNA target interactions, providing a valuable addition to existing approaches. To our knowledge, this is the first report that the miR-548ah-5p/THBD axis is a key regulatory axis in HF, suggesting a potential new avenue for further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.